Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
Author(s) -
Jan Grimm,
David G. Kirsch,
Stephen D. Windsor,
Carla F. Bender Kim,
Philip M. Santiago,
Vasilis Ntziachristos,
Tyler Jacks,
Ralph Weissleder
Publication year - 2005
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0503920102
Subject(s) - proteases , cathepsin , in vivo , lung cancer , cathepsin b , biology , gene expression profiling , molecular imaging , preclinical imaging , microbiology and biotechnology , gene expression , pathology , cancer research , gene , medicine , enzyme , biochemistry , genetics
Using gene expression profiling, we identified cathepsin cysteine proteases as highly up-regulated genes in a mouse model of human lung adenocarcinoma. Overexpression of cathepsin proteases in these lung tumors was confirmed by immunohistochemistry and Western blotting. Therefore, an optical probe activated by cathepsin proteases was selected to detect murine lung tumors in vivo as small as 1 mm in diameter and spatially separated. We generated 3D maps of the fluorescence signal and fused them with anatomical computed tomography images to show a close correlation between fluorescence signal and tumor burden. By serially imaging the same mouse, optical imaging was used to follow tumor progression. This study demonstrates the capability for molecular imaging of a primary lung tumor by using endogenous proteases expressed by a tumor. It also highlights the feasibility of using gene expression profiling to identify molecular targets for imaging lung cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom